Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DX25F6RSB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,514
Award facts
- Contract value 100% obligated
- $5,513.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count package) valued at $5,513.58. This firm fixed-price delivery order, with an ultimate completion date of July 16, 2025, represents a non-competitive award under a larger contract vehicle. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the company's comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills federal medical procurement needs primarily for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company's SPE2DX contract encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals, and related medical commodities across multiple therapeutic domains to support Defense Health Agency customers, the U.S. Coast Guard, and other government healthcare systems worldwide. The delivery order for Myrbetriq ER, a urological medication, reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and represents one of numerous pharmaceutical deliveries executed under this prime indefinite delivery contract.
Quick answers
Who was awarded contract SPE2DX25F6RSB?
SPE2DX25F6RSB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 15, 2025.
How much is contract SPE2DX25F6RSB worth?
The government has obligated $5,514 on SPE2DX25F6RSB.
Is contract SPE2DX25F6RSB an order under another contract?
Yes. SPE2DX25F6RSB is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6RSB competed?
The extent of competition for SPE2DX25F6RSB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award